Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer's Disease

被引:6
作者
Tahmasebi, R. [1 ]
Zehetmayer, S. [2 ]
Stoegmann, E. [1 ]
Lehrner, Johann [1 ]
机构
[1] Med Univ Vienna, Dept Neurol, Wahringer Gurtel 18-20, A-1097 Vienna, Austria
[2] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria
关键词
Cognitive dysfunction; Neuropsychology; Olfaction; Memory; ODOR IDENTIFICATION; IMPAIRMENT; DISCRIMINATION; PREVALENCE; DEFICITS; ANOSOGNOSIA; PERFORMANCE; INVENTORY; SUBTYPES; RATINGS;
D O I
10.1007/s12078-019-09267-7
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Introduction Hyposmia and metacognitive errors are related to aging, depression, male gender, and cognitive decline. The current study investigated the awareness of olfactory dysfunction in subjective cognitive decline (SCD), mild cognitive impairment (MCI), and Alzheimer's disease (AD), as well as the influence of additional factors. Methods A sample of 641 patients, including controls, SCD, non-amnestic MCI (naMCI), amnestic MCI (aMCI), and AD patients, was assessed with the Sniffin' Sticks odor identification test (OIT) and the subjective olfactory capability (SOC) scale, in addition to measures of depressive symptoms, verbal memory, and executive functioning. Olfactory awareness groups were formed by means of the cutoffs of the OIT and the SOC. Results Moderate and small, although significant, correlations between the OIT and the SOC were found among the study groups, with a significant discrimination of measured olfactory function via subjective assessment existing among controls but not among patients with AD. Of all AD patients, 34% overrated their sense of smell while 21% correctly identified themselves as being hyposmic, as opposed to corresponding 6% and 1% of healthy elderly. Overraters and correct hyposmic participants showed higher age and worse verbal memory and executive functions. Conclusions Reduced odor identification might underlie the same pathological changes within the brain as cognitive impairment and could serve as an additional marker for the development of AD.
引用
收藏
页码:59 / 70
页数:12
相关论文
共 48 条
[1]  
[Anonymous], DIAGNOSTISCHES STAT
[2]   Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease [J].
Bahar-Fuchs, Alex ;
Moss, Simon ;
Rowe, Christopher ;
Savage, Greg .
INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (07) :1097-1106
[3]   Evaluation of olfactory dysfunction in neurodegenerative diseases [J].
Barresi, Marina ;
Ciurleo, Rosella ;
Giacoppo, Sabrina ;
Cuzzola, Valeria Foti ;
Celi, Debora ;
Bramanti, Placido ;
Marino, Silvia .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) :16-24
[4]   Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients [J].
Behl, Pearl ;
Bocti, Christian ;
Swartz, Richard H. ;
Gao, FuQiang ;
Sahlas, Demetrios J. ;
Lanctot, Krista L. ;
Streiner, David L. ;
Black, Sandra E. .
ARCHIVES OF NEUROLOGY, 2007, 64 (02) :266-272
[5]  
Brämerson A, 2004, LARYNGOSCOPE, V114, P733
[6]  
Cohen J., 1988, Statistical Power Analysis for the Behavioral Sciences., V2nd, DOI [DOI 10.1007/978-1-4684-5439-0_2, DOI 10.4324/9780203771587, 10.4324/9780203771587]
[7]   Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community [J].
Devanand, D. P. ;
Lee, Seonjoo ;
Manly, Jennifer ;
Andrews, Howard ;
Schupf, Nicole ;
Doty, Richard L. ;
Stern, Yaakov ;
Zahodne, Laura B. ;
Louis, Elan D. ;
Mayeux, Richard .
NEUROLOGY, 2015, 84 (02) :182-189
[8]   Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up [J].
Devanand, DP ;
Michaels-Marston, KS ;
Liu, XH ;
Pelton, GH ;
Padilla, M ;
Marder, K ;
Bell, K ;
Stern, Y ;
Mayeux, R .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (09) :1399-1405
[9]   Olfaction in patients with mild cognitive impairment and Alzheimer's disease [J].
Djordjevic, Jelena ;
Jones-Gotman, Marilyn ;
De Sousa, Kathy ;
Chertkow, Howard .
NEUROBIOLOGY OF AGING, 2008, 29 (05) :693-706
[10]  
Doty RL, 2017, LANCET NEUROL, V16, P478, DOI 10.1016/S1474-4422(17)30123-0